Welcome to MCL!

This is the Consortium for Molecular and Cellular Characterization of Screen-Detected Lesions.

The MCL Consortium consists of independent, multi-disciplinary teams that undertake comprehensive molecular and cellular characterizations of tumor tissue, cell, and microenvironment components to distinguish screen-detected early lesions from interval and symptom-detected cancers.

If you'd like to join us, fill out the registration form.


MCL 11th Semiannual Steering Committee Meeting

The MCL Consortium 11th Virtual Steering Committee Meeting: March 19th, 2021, 10am - 5:30pm ET

Agenda and Call Information

Meeting Minutes

Virtual Pathology Workshop: TBA

 Agenda and Call Information

Virtual Data, Informatics, and Resource Sharing Subcommittee Session: March 17th, 2021, 6pm - 8pm ET

Agenda and Call Information